These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3034497)
1. Cellular and molecular biology of lipoprotein metabolism: characterization of lipoprotein receptor-ligand interactions. Mahley RW; Innerarity TL; Weisgraber KH; Rall SC; Hui DY; Lalazar A; Boyles JK; Taylor JM; Levy-Wilson B Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():821-8. PubMed ID: 3034497 [No Abstract] [Full Text] [Related]
2. Molecular biology of human apolipoproteins B and E and associated diseases of lipoprotein metabolism. Zannis VI Adv Lipid Res; 1989; 23():1-64. PubMed ID: 2560890 [No Abstract] [Full Text] [Related]
3. [Human apolipoprotein E: polymorphism and binding domain of the receptors]. Bekaert ED; Ayrault-Jarrier M; Polonovski J Biochimie; 1986 May; 68(5):629-37. PubMed ID: 3015256 [TBL] [Abstract][Full Text] [Related]
4. The molecular basis of atherosclerosis: concepts derived from studies of lipoprotein metabolism and cell biology. Mahley RW Clin Invest Med; 1986 Nov; 9(4):304-8. PubMed ID: 3026707 [No Abstract] [Full Text] [Related]
5. RNA editing: a novel mechanism for the regulation of dietary cholesterol absorption. The Humphry Davy Rolleston lecture 1989. Scott J J R Coll Physicians Lond; 1990 Apr; 24(2):101-6. PubMed ID: 1693686 [No Abstract] [Full Text] [Related]
7. [Apolipoprotein B100 and LDL receptors: genetic and metabolic aspects]. Chapman MJ Journ Annu Diabetol Hotel Dieu; 1991; ():35-7. PubMed ID: 1653378 [No Abstract] [Full Text] [Related]
8. Functional domains of apolipoprotein E and apolipoprotein B. Innerarity TL; Weisgraber KH; Rall SC; Mahley RW Acta Med Scand Suppl; 1987; 715():51-9. PubMed ID: 3035881 [No Abstract] [Full Text] [Related]
9. [Receptor endocytosis of polyenic acids: sensitivity and resistance to atherosclerosis (review of the literature)]. Titov VN Klin Lab Diagn; 1999 Jan; (1):3-8. PubMed ID: 10097487 [No Abstract] [Full Text] [Related]
10. Very low density lipoprotein apolipoproteins B-100 and E turnover in control subjects using L-[1-13C]-leucine. Collins A; Venkatesan S; Garcia P; Pacy PJ; Halliday D Biochem Soc Trans; 1992 May; 20(2):102S. PubMed ID: 1397512 [No Abstract] [Full Text] [Related]
11. Type III hyperlipoproteinemia: a focus on lipoprotein receptor-apolipoprotein E2 interactions. Innerarity TL; Hui DY; Bersot TP; Mahley RW Adv Exp Med Biol; 1986; 201():273-88. PubMed ID: 3026150 [No Abstract] [Full Text] [Related]
12. Cellular metabolism of apoprotein-B containing lipoproteins: the role of apoproteins, heparan sulfate and cellular receptors. Sehayek E Isr J Med Sci; 1996 Jun; 32(6):445-8. PubMed ID: 8682649 [No Abstract] [Full Text] [Related]
13. [Apolipoprotein E in lipid transport]. Gómez Gerique JA Rev Clin Esp; 1992 Feb; 190(3):137-48. PubMed ID: 1313988 [No Abstract] [Full Text] [Related]
14. Modern management of hyperlipidemia. Grundy SM Compr Ther; 1984 Sep; 10(9):46-53. PubMed ID: 6091992 [No Abstract] [Full Text] [Related]
16. Receptor mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells. Gröne HJ; Walli AK; Gröne E; Krämer A; Clemens MR; Seidel D Kidney Int; 1990 Jun; 37(6):1449-59. PubMed ID: 2163465 [TBL] [Abstract][Full Text] [Related]
18. [Interaction between genes and diet as a determinant of the plasma levels of cholesterol]. López Miranda J; Ordovás JM; Pérez Jiménez F Med Clin (Barc); 1998 Oct; 111(14):546-51. PubMed ID: 9859082 [No Abstract] [Full Text] [Related]
19. Apolipoprotein function in health and disease: insights from natural mutations. Franceschini G Eur J Clin Invest; 1996 Sep; 26(9):733-46. PubMed ID: 8889435 [No Abstract] [Full Text] [Related]